Response in patients treated with Ven-Aza or Pbo-Aza by risk stratification. (A) Remission rates in patients treated with Ven-Aza or Pbo-Aza in the higher-, intermediate-, and lower-benefit groups. (B) OS in patients treated with Ven-Aza in the higher-, intermediate-, and lower-benefit groups.